CCAT2 and colorectal carcinoma: As the clinical relevance of serum CCAT2 and HULC as biomarkers of CRC was not previously studied, we also investigated serum CCAT2 and HULC expression in AP and CRC patients, their correlation with clinicopathological data, and their potential as non-invasive biomarkers of CRC.